| Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States. | |
| | |
MedLine Citation:
|
PMID: 19672151 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
The pathway that emerging medical technologies take to incorporation into routine medical care in the United States is a product of the social, economic, and political milieu. Our review explores how this milieu brought the incorporation of proton beam therapy into the healthcare delivery system to its current point. We look at how new technologies are presently accepted into this system and discuss the emerging trends--such as the use of evidence-based assessment of technology, coverage with evidence policies, and comparative effectiveness analysis--that are affecting proton beam therapy's effort to finds its place in the pantheon of available medical treatments for patients with cancer. |
| | |
Authors:
|
Michael L Steinberg; Andre Konski |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cancer journal (Sudbury, Mass.) Volume: 15 ISSN: 1528-9117 ISO Abbreviation: Cancer J Publication Date: 2009 Jul-Aug |
Date Detail:
|
Created Date: 2009-08-12 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100931981 Medline TA: Cancer J Country: United States |
Other Details:
|
Languages: eng Pagination: 333-8 Citation Subset: IM |
Affiliation:
|
Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6951, USA. msteinberg@mednet.ucla.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparison of carbon ions versus protons.
Next Document: Delayed recognition of profound hearing loss in a 7-year-old girl with a neurological condition.